Biotech

All Articles

OS Therapies refiles $6M IPO to cash HER2 drug, preclinical ADCs

.Operating system Therapies are going to note on the NYSE American stock exchange this morning by me...

ALX's fizzling CD47 reaction rate sends out stock spiraling down

.ALX Oncology's phase 2 stomach cancer cells feedback fee has actually deteriorated. After observing...

Ionis axes eye health condition from targets of Roche-partnered possibility after information disappoint

.Yet Another of Ionis Pharmaceuticals' key midphase readouts has actually disappointed assumptions, ...

Biogen's CEO claimed no high-risk handle 2023. He prepares to become bold

.While Biogen's pharma peers are actually hunting for late-stage assets along with little threat, ch...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Biography has been actually a biotech seeking a pipe after it junked its lead possessions ov...

Biogen ignores Denali Alzheimer's collab

.Biogen has handed back civil rights to an early Alzheimer's ailment course to Denali Therapies, lea...

Takeda taps new mind of US oncology organization-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable management hirings, firings as wel...

Vertex, hammered by AATD again, goes down 2 resources on throw away pile

.Vertex's attempt to address an unusual genetic ailment has struck one more drawback. The biotech sh...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of workers

.Vir Medical's second-quarter profits file had not been except big news. The firm welcomed a trio of...

Galapagos pauses CAR-T cell therapy litigation over Parkinsonism case

.Galapagos has actually stopped registration in a test of a BCMA-directed CAR-T cell treatment, push...